Regenerative Medical Technology (RMTG) EPS (Basic) Growth (5y) (2023 - 2026)
Powered by 
Analysis
Regenerative Medical Technology (RMTG) EPS (Basic) Growth (5y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.58 Bn | 251.50 Mn |
| 5 | uniQure | 3.00 Bn | 3.00 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.95 Bn | 1.79 Bn | 56.40 Mn |
| 10 | Regenerative Medical Technology | 1.18 Mn | -139,694.93 | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14.68% |
| Mar 31, 2026 | -28.02% |
| Dec 31, 2025 | 9.71% |
| Sep 30, 2025 | -39.15% |
| Jun 30, 2025 | -5.79% |
| Mar 31, 2025 | 0.43% |
| Dec 31, 2024 | 29.16% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | -32.92% |
| Mar 31, 2024 | -30.90% |
| Dec 31, 2023 | -24.12% |
| Sep 30, 2023 | -11.54% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | 28.93% |